BUZZ-US-listed healthcare firms down amid Middle East conflict

Reuters2023-10-09

** Shares of U.S.-listed healthcare firms based in or with operations in Israel down 4%-12% premarket amid military conflict in the Middle East

** U.S.-listed shares of Teva Pharmaceutical , the world's largest generic drugmaker, drops 4%

** Shares of Gamida Cell down ~10%, Vascular Biogenics slide 8.2%, IceCure Medical fell 12.2%

** Protalix BioTherapeutics down 5.5% despite a statement saying it does not anticipate a disruption in supply of Elelyso, which treats a rare genetic disorder

** Other U.S.-listed shares of healthcare firm such as BioLineRX , InterCure , Can-Fite BioPharma

are down nearly 7%

(Reporting by Khushi Mandowara in Bengaluru)

((Khushi.Mandowara@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment